1 / 37

CMS Kidney Disease Patient Education Benefit: Hit or Miss?

CMS Kidney Disease Patient Education Benefit: Hit or Miss?. Linda Shenton RN, MN, ACNP-BC, CNN-NP Nephrology Associates, P.A. Objectives. 1. Identify the basic structure of the CMS Kidney Disease Patient Education (KDPE) benefit.

hani
Download Presentation

CMS Kidney Disease Patient Education Benefit: Hit or Miss?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CMS Kidney Disease Patient Education Benefit: Hit or Miss? Linda Shenton RN, MN, ACNP-BC, CNN-NP Nephrology Associates, P.A.

  2. Objectives 1. Identify the basic structure of the CMS Kidney Disease Patient Education (KDPE) benefit. 2. Discuss key components of the CMS KDPE of particular interest to nephrology nurses. 3. Critique of the CMS KDPE benefit.

  3. To provide KDE services “…tailored to meet the needs of the individual beneficiary involved, to provide opportunities to actively participate in the choice of therapy, and provide information regarding…” -Management of comorbidities (for the purpose of delaying dialysis) -Prevention of uremic complications -Renal replacement options

  4. Objective OneIdentify the basic structure of the CMS KDPE benefit.

  5. Structure • Beneficiaries eligible for coverage • Qualified person • Limitations for coverage • Standards for content • Outcomes assessment

  6. Beneficiaries Eligible for Coverage Medicare part B covered beneficiaries Diagnosed with Stage IV CKD (severe decrease in GFR; GFR value of 15-29ml/min/1.73m²) Referral from the physician managing the CKD

  7. Qualified Persons Medicare Part B covers KDPE services by a ‘qualified person’ meaning a: -Physician -Physician assistant -Nurse practitioner -Clinical nurse specialist

  8. Non-qualified Persons? Quoting directly from the Medicare document: “ The following providers are not ‘qualified persons’ and are excluded from furnishing KDPE services: a hospital, CAH, SNF, HHA, or hospice located outside of a rural area or a renal dialysis facilities.”

  9. Limitations for Coverage Medicare Part B covers KDE services. 1. Up to six (6) sessions as a beneficiary lifetime maximum. Session is 1 hour. In order to bill for a session, a session must be at least 31 minutes in duration. A session that lasts at least 31 minutes, but less than one hour still constitutes 1 session. 2. On an individual basis or in group settings; if the services are provided in a group setting, a group consists of 2 to 20 individuals who need not all be Medicare beneficiaries.

  10. Standards for Content The required content is divided into four categories. A. The management of comorbidities, including delaying the need for dialysis, which includes, but is not limited to, the following topics: 1. Prevention and treatment of cardiovascular disease 2. Prevention and treatment of diabetes 3. Hypertension management

  11. Standards for Content (cont.) 4. Anemia management 5. Bone disease and disorders of calcium and phosphorous metabolism management 6. Symptomatic neuropathy management 7. Impairments in functioning and well- being

  12. Standards for Content (cont.) B. Prevention of uremic complications, which includes, but is not limited to, the following topics: 1. Information on how the kidneys work and what happens when kidneys fail 2. Understanding if remaining kidney function can be protected, preventing disease progression and realistic chances of survival

  13. Standards for Content (cont.) 3. Diet restrictions 4. Medication review, including how each medication works, possible side effects and minimization of side effects, the importance of compliance, and informed decision making if the patient decides not to take a specific drug

  14. Standards for Content (cont.) C. Therapeutic options, treatment modalities and settings, advantages and disadvantages of each treatment option, and how the treatments replace the kidney, including, but not limited to, the following: 1. Hemodialysis - both at home and in-facility 2. Peritoneal dialysis (PD), including intermittent PD, continuous ambulatory PD, and continuous cycling PD, both at home and in-facility 3. All dialysis access options for hemodialysis and peritoneal dialysis 4. Transplantation

  15. Standards for Content (cont.) D. Opportunities for beneficiaries to actively participate in the choice of therapy and be tailored to meet the needs of the individual beneficiary involved, which includes, but is not limited to, the following topics: 1. Physical symptoms 2. Impact on family and social life 3. Exercise 4. The right to refuse treatment 5. The impact on work and finances 6. The meaning of test results 7. Psychological impact

  16. Outcomes Assessment “Qualified persons that provide KDE services must develop outcomes assessments that are designed to measure beneficiary knowledge about CKD and its treatment. The assessment must be administered to the beneficiary during a KDE session, and must be made available to CMS upon request. The outcomes assessments serve to assist KDE educators and CMS in improving subsequent KDE programs, patient understanding, and assess program effectiveness of…”

  17. Outcomes Assessment (cont.) 1. Preparing the beneficiary to make informed decisions about their healthcare options related to CKD. 2. Meeting the communication needs of underserved populations, including persons with disabilities, persons with limited English proficiency, and persons with health literacy needs.

  18. Objective TwoDiscuss key components of the CMS KDPE of particular interest to nephrology nurses.

  19. Components • Required content • Presentation of content • Outcome assessment tools

  20. Required Content • Diabetes The most common cause of CKD world-wide • Hypertension More than 50 million Americans have hypertension requiring treatment • Cardiovascular Disease 10-20 times greater mortality in patients on dialysis

  21. Required Content cont. • Anemia Develops as early as stage 2 Contributes to development of LVH, CHF & ischemic heart disease • Bone and Mineral Disorder Begins as early as stage 3 • Diet and Fluid Restriction

  22. Required Content cont. • Options: Hemodialysis Peritoneal dialysis Transplant Hospice

  23. Presentation of Content Things to consider: • Depression • Short attention span • Education level • Denial • Family support • Literacy

  24. Outcome Assessment Tools • Do not reinvent the wheel: ANA, ANNA, NKF, RPA all have patient education information guidelines, assessment tools and programs that can be adapted to most topics.

  25. Outcome Assessment Tools

  26. Nephrology Nursing Journal, Mar/Apr2010, Vol. 37 Issue 2, p143-148, 6p, 1 chartChart; found on p146

  27. Outcome Assessment Tools (cont.) • Reading Level • Written vs. pictorial • Oral • Multiple choice

  28. Objective Three Critique of the CMS KDPE benefit.

  29. Hit • Funding for any patient education • Extensive content requirements • Nephrology driven service • Adjusting reimbursement per RPA • NP/CNS/PA involvement

  30. Miss • Excluding RN’s from participation • Insufficient number of sessions • Sessions too long for patient population attention span

  31. Close…but no cigar • Starting education at CKD stage 4 • Increased reimbursement but excludes incident to billing for NP, CNS, PA

  32. Bibliography AHRQ Stakeholders’. 2008. Executive Summary of Medicare Coverage of Kidney Disease Patient Education Services. Rockville, MD. American Nephrology Nursing Association. www.annanurse.org Counts, Caroline. (2008). Core curriculum for nephrology nursing. 2008-01. Department of Health & Human Services. 2009. Pub 100-02 Medicare Benefit Policy. Washington, D.C. National Kidney Foundation. www.kidney.org Nephrology Nursing Journal. Mar/Apr2010, Vol. 37 Issue 2, p143-148. Renal Physicians Association. www.renalmd.org

More Related